Development of a New Rapid Simultaneous Molecular Assay for the Detection of STI Pathogens and Drug Resistance-Associated Mutations

Molecular Diagnosis and Therapy · Published 2025-01-17 · DOI 10.1007/s40291-024-00769-z

Authors being retrieved — see the publisher record. https://doi.org/10.1007/s40291-024-00769-z

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year: 2025

Related articles

Development of a Point-of-Care Recombinase Polymerase Amplification Assay for Detection of Neisseria gonorrhoeae and Ceftriaxone-Resistance Associated penA Allele 60.001 · Molecular Diagnosis and Therapy · 2026 · Cites or is cited by this article · Same journal
Clinical, Genetic, Morphological and Functional Correlations in a Large Series of Patients with Primary Ciliary Dyskinesia: A Heterogeneous Disease with a Controversial Diagnosis · Molecular Diagnosis and Therapy · 2025 · Same journal
Gastric Cancer Treatment New Chapter: Organoid Models Leading Personalized Medicine · Molecular Diagnosis and Therapy · 2025 · Same journal
Advancing Medulloblastoma Treatment: Molecular Mechanisms, Drug Repurposing, and Precision Therapies · Molecular Diagnosis and Therapy · 2025 · Same journal
Tividenofusp Alfa: First Approval · Molecular Diagnosis and Therapy · 2026 · Same journal
Development of a Nomogram to Predict Therapeutic Resistance in Metastatic Melanoma Using Longitudinal ctDNA Kinetics · Molecular Diagnosis and Therapy · 2026 · Same journal
The Future of Chemogenetics for the Treatment of Spasticity · Molecular Diagnosis and Therapy · 2025 · Same journal
TROP2-Targeted Therapeutics in Development to Treat Gastrointestinal Tumors · Molecular Diagnosis and Therapy · 2026 · Same journal
Co-encapsulation in Solid Lipid Nanoparticles and Nanostructured Lipid Carriers as an Emerging Therapeutic Strategy · Molecular Diagnosis and Therapy · 2026 · Same journal
Marnetegragene Autotemcel: First Approval · Molecular Diagnosis and Therapy · 2026 · Same journal